-
22Overthrowing the Tyranny of the Journal Impact FactorAmerican Journal of Bioethics 13 (7): 1-2. 2013.No abstract
-
30A Commentary on Oocyte Donation for Stem Cell Research in South KoreaAmerican Journal of Bioethics 6 (1). 2006.No abstract
-
16Blood, sweat and tearsAmerican Journal of Bioethics 6 (3). 2006.This Article does not have an abstract
-
18CPR and Ventricular Assist Devices: The Challenge of Prolonging Life Without Guaranteeing HealthAmerican Journal of Bioethics 17 (2): 1-2. 2017.
-
67Federalism and bioethics: States and moral pluralismHastings Center Report 37 (6): 24-35. 2007.Bioethicists are often interested mostly in national standards and institutions, but state governments have historically overseen a wide range of bioethical issues and share responsibility with the federal government for still others. States ought to have an important role. By allowing for multiple outcomes, the American federal system allows a better fit between public opinion and public policies.
-
10Finding the Right Tools for Assessing Quality of Clinical Ethics ConsultationAmerican Journal of Bioethics 16 (3): 1-2. 2016.
-
Biology & epistemologyIn Richard Creath & Jane Maienschein (eds.), Biology and epistemology, Cambridge University Press. 1999.
-
36Clinical Ethics Consultation: A Need for EvidenceAmerican Journal of Bioethics 15 (1): 1-2. 2015.
-
16AJOB 2.0: Taking Bioethics to a New LevelAmerican Journal of Bioethics 14 (8): 1-2. 2014.No abstract
-
12Beyond the IRB: Local Service Versus Global OversightAmerican Journal of Bioethics 11 (5): 1-2. 2011.
-
28A new era for AJOBAmerican Journal of Bioethics 4 (3). 2004.This Article does not have an abstract
-
41Adrift in the gray zone: IRB perspectives on research in the learning health systemAJOB Empirical Bioethics 7 (2): 125-134. 2016.
-
58Translating Stem Cell Research: Challenges at the Research FrontierJournal of Law, Medicine and Ethics 38 (2): 267-276. 2010.There are many kinds of clinical trials. The regulatory framework within which most drug development takes place appears to be the one that is to be applied to the development of novel stem cell-based clinical trials. In the standard drug development model, appropriate pre-clinical research is conducted, and investigators or research sponsors submit an investigational new drug application to the Food and Drug Administration.If approved, typical clinical trials start with Phase I, which is usuall…Read more
-
12Innocent Fun or “Microslavery”?Hastings Center Report 44 (6): 38-46. 2014.In 2011, Ingmar Riedel‐Kruse's bioengineering laboratory at Stanford University publicized an application that uses paramecia for what the researchers termed “biotic games.” These games make use of living organisms, computer programs, and lab equipment to implement games like Pong, Pac‐man, and soccer. Gamesand related activities are often considered nonserious or trivial, whereas life, biological systems, and science are treated very seriously in moral analysis and public perception. The manipu…Read more
-
60Strangers at the benchside: Research ethics consultationAmerican Journal of Bioethics 8 (3). 2008.Institutional ethics consultation services for biomedical scientists have begun to proliferate, especially for clinical researchers. We discuss several models of ethics consultation and describe a team-based approach used at Stanford University in the context of these models. As research ethics consultation services expand, there are many unresolved questions that need to be addressed, including what the scope, composition, and purpose of such services should be, whether core competencies for co…Read more
-
48States and Moral PluralismHastings Center Report 37 (6): 24. 2007.Bioethicists are often interested mostly in national standards and institutions, but state governments have historically overseen a wide range of bioethical issues and share responsibility with the federal government for still others. States ought to have an important role. By allowing for multiple outcomes, the American federal system allows a better fit between public opinion and public policies.
-
24Sexless Reproduction: A Status SymbolAmerican Journal of Bioethics 11 (3): 1-1. 2011.This Article does not have an abstract
-
33Disease Gene Patenting: The Clinician's DilemmaCambridge Quarterly of Healthcare Ethics 7 (4): 433-435. 1998.One strategy for defenders of gene patenting is to adopt a constructivist interpretation of genetic testing to avoid the I argue that accepting this view (which seems to be the approach of the U.S. Office of Patents and Trademarks) results in an intolerable dilemma for physicians. They must either infringe patents or fail to act on all the medically relevant information they possess (malpractice)
-
26The Instrumental Role of Hospital Ethics Committees in Policy WorkAmerican Journal of Bioethics 12 (11): 1-2. 2012.No abstract